These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10719944)

  • 1. Multiple dose pharmacokinetics of oral transmucosal fentanyl citrate in healthy volunteers.
    Egan TD; Sharma A; Ashburn MA; Kievit J; Pace NL; Streisand JB
    Anesthesiology; 2000 Mar; 92(3):665-73. PubMed ID: 10719944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose pharmacokinetics of fentanyl sublingual spray and oral transmucosal fentanyl citrate in healthy volunteers: a randomized crossover study.
    Parikh N; Goskonda V; Chavan A; Dillaha L
    Clin Ther; 2013 Mar; 35(3):236-43. PubMed ID: 23497761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose proportionality and pharmacokinetics of oral transmucosal fentanyl citrate.
    Streisand JB; Busch MA; Egan TD; Smith BG; Gay M; Pace NL
    Anesthesiology; 1998 Feb; 88(2):305-9. PubMed ID: 9477048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation selection and pharmacokinetic comparison of fentanyl buccal soluble film with oral transmucosal fentanyl citrate: a randomized, open-label, single-dose, crossover study.
    Vasisht N; Gever LN; Tagarro I; Finn AL
    Clin Drug Investig; 2009; 29(10):647-54. PubMed ID: 19715381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacokinetic study to compare two simultaneous 400 microg doses with a single 800 microg dose of oral transmucosal fentanyl citrate.
    Lee M; Kern SE; Kisicki JC; Egan TD
    J Pain Symptom Manage; 2003 Aug; 26(2):743-7. PubMed ID: 12906959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute and relative bioavailability of fentanyl buccal tablet and oral transmucosal fentanyl citrate.
    Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
    J Clin Pharmacol; 2007 Mar; 47(3):343-50. PubMed ID: 17322146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study.
    Portenoy RK; Payne R; Coluzzi P; Raschko JW; Lyss A; Busch MA; Frigerio V; Ingham J; Loseth DB; Nordbrock E; Rhiner M
    Pain; 1999 Feb; 79(2-3):303-12. PubMed ID: 10068176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative potency of oral transmucosal fentanyl citrate compared with intravenous morphine in the treatment of moderate to severe postoperative pain.
    Lichtor JL; Sevarino FB; Joshi GP; Busch MA; Nordbrock E; Ginsberg B
    Anesth Analg; 1999 Sep; 89(3):732-8. PubMed ID: 10475315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and relative bioavailability of fentanyl pectin nasal spray 100 - 800 µg in healthy volunteers.
    Fisher A; Watling M; Smith A; Knight A
    Int J Clin Pharmacol Ther; 2010 Dec; 48(12):860-7. PubMed ID: 21084042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain.
    Christie JM; Simmonds M; Patt R; Coluzzi P; Busch MA; Nordbrock E; Portenoy RK
    J Clin Oncol; 1998 Oct; 16(10):3238-45. PubMed ID: 9779697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral transmucosal fentanyl citrate: overview of pharmacological and clinical characteristics.
    Mystakidou K; Katsouda E; Parpa E; Vlahos L; Tsiatas ML
    Drug Deliv; 2006; 13(4):269-76. PubMed ID: 16766468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faster absorption and higher systemic bioavailability of intranasal fentanyl spray compared to oral transmucosal fentanyl citrate in healthy subjects.
    Nave R; Schmitt H; Popper L
    Drug Deliv; 2013; 20(5):216-23. PubMed ID: 23650968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of the intravenous formulation of fentanyl citrate administered orally in children undergoing general anesthesia.
    Wheeler M; Birmingham PK; Lugo RA; Heffner CL; Coté CJ
    Anesth Analg; 2004 Nov; 99(5):1347-1351. PubMed ID: 15502029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral transmucosal fentanyl citrate (OTFC) in the treatment of breakthrough pain].
    Borgbjerg FM; Rosenberg J
    Ugeskr Laeger; 2000 Sep; 162(39):5237-40. PubMed ID: 11043058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral transmucosal fentanyl citrate for premedication in adults.
    Macaluso AD; Connelly AM; Hayes WB; Holub MC; Ramsay MA; Suit CT; Hein HA; Swygert TH
    Anesth Analg; 1996 Jan; 82(1):158-61. PubMed ID: 8712394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption and bioavailability of oral transmucosal fentanyl citrate.
    Streisand JB; Varvel JR; Stanski DR; Le Maire L; Ashburn MA; Hague BI; Tarver SD; Stanley TH
    Anesthesiology; 1991 Aug; 75(2):223-9. PubMed ID: 1859010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients.
    Farrar JT; Cleary J; Rauck R; Busch M; Nordbrock E
    J Natl Cancer Inst; 1998 Apr; 90(8):611-6. PubMed ID: 9554444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic comparisons of three nasal fentanyl formulations; pectin, chitosan and chitosan-poloxamer 188.
    Fisher A; Watling M; Smith A; Knight A
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):138-45. PubMed ID: 20137766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial.
    Mercadante S; Radbruch L; Davies A; Poulain P; Sitte T; Perkins P; Colberg T; Camba MA
    Curr Med Res Opin; 2009 Nov; 25(11):2805-15. PubMed ID: 19792837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.